Expanded Access Policy

Expanded Access Policy

Consistent with LEO Pharma’s mission to help people achieve healthy skin, LEO Pharma is dedicated to developing new therapies that have a positive impact on patient health. 

LEO Pharma works in alignment with health authorities to conduct clinical trials that address unmet medical needs and make new therapies available to patients as quickly as possible.

Information about LEO Pharma’s clinical trials, including eligibility and locations, is available at clinicaltrials.gov.  LEO Pharma recognizes the importance of Expanded Access Programs and may update this policy based on data from ongoing drug development programs and future clinical trials.

Expanded access requests may be submitted by a licensed physician to LEO Pharma’s Medical Information department at globalmedicglobalmedical_info_dk@leo-pharma.com LEO Pharma plans to acknowledge the receipt of specific inquiries within five (5) business days.